Douglas Warner
Hoofd Techniek/Wetenschap/O&O bij EFFECTOR THERAPEUTICS, INC.
Vermogen: - $ op 30-04-2024
Oorsprong van het eerstegraads netwerk van Douglas Warner
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 14 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Douglas Warner via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| University of California, Berkeley | College/University | Doctorate Degree Undergraduate Degree Corporate Officer/Principal | |
eFFECTOR Therapeutics Operations, Inc.
 eFFECTOR Therapeutics Operations, Inc. Miscellaneous Commercial ServicesCommercial Services eFFECTOR Therapeutics Operations, Inc. discovers and develops translation regulators. It offers small molecule therapeutics that control gene expression for the treatment of cancer and other serious diseases. Its pipeline of translation regulators includes eFT508, eIF4E, and eIF4A. The company was founded by James R. Appleman, Kevin L. Eastwood, Siegfried Reich, Davide Ruggero, Kevan Shokat, and Stephen T. Worland in 2012 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Founder Director/Board Member Director/Board Member | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Kellogg School of Management | College/University | Masters Business Admin Masters Business Admin | |
| PRINCIPIA BIOPHARMA INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| University of Michigan | College/University | Undergraduate Degree Doctorate Degree | |
| APPLIED MOLECULAR TRANSPORT INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
Pomona College
 Pomona College Other Consumer ServicesConsumer Services Pomona College offers curriculum in the arts, humanities, social sciences and natural sciences. It was founded in 1887 and it is headquartered in Claremont, CA | College/University | Director/Board Member Undergraduate Degree | |
Anadys Pharmaceuticals, Inc.
 Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | Pharmaceuticals: Major | Chief Executive Officer | |
Alantos Pharmaceuticals Holding, Inc.
 Alantos Pharmaceuticals Holding, Inc. Pharmaceuticals: MajorHealth Technology Alantos Pharmaceuticals Holding, Inc. manufactures bio-pharmaceutical products. The firm develops small molecule compounds for inflammatory cytokine pathways. The company was founded in 1999 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Navitor Pharmaceuticals, Inc.
 Navitor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Navitor Pharmaceuticals, Inc. develops medicine for age-related diseases. Its drug discovery platform targets mTORC1, which responds to and integrates the cell’s response to nutrient availability and plays a key role in protein synthesis and cellular growth. The company was founded by Alan L. Crane, David Sabatini and David Goldfarb and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
Abingworth Management, Inc.
 Abingworth Management, Inc. Investment ManagersFinance Abingworth Management, Inc. invests in life sciences and biomedical companies. The firm's investment in enables technologies, devices and instrumentation as well as companies developing products in therapeutic areas. The company was founded in 1973 and is headquartered in Menlo Park, CA. | Investment Managers | Private Equity Investor | |
Nimbus Apollo, Inc.
 Nimbus Apollo, Inc. Pharmaceuticals: MajorHealth Technology Nimbus Apollo, Inc. provides drug discovery research services. The company is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
CalciMedica, Inc. (US)
 CalciMedica, Inc. (US) BiotechnologyHealth Technology CalciMedica, Inc. is a holding company, which engages in drug development. It discovers and develops novel small molecule drugs for the treatment of inflammatory and autoimmune disorders and organ transplant rejection. The company was founded by Gonul Velicelebi, Kenneth Stauderman, Anjana Rao, Patrick Hogan, Stefan Feske, Michael Harpold, Tom Reed, and Jack Roos in December 2006 and is headquartered in La Jolla, CA. | Biotechnology | Director/Board Member | |
Q32 Bio, Inc.
 Q32 Bio, Inc. BiotechnologyHealth Technology Q32 Bio Operations, Inc. develops immunomodulatory therapies with protein based molecules using a platform. The company was founded by Shelia Violette and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Indiana University | College/University | Undergraduate Degree | |
| University of California, Davis | College/University | Doctorate Degree | |
| University of California | College/University | Corporate Officer/Principal | |
| EISAI CO., LTD. | Pharmaceuticals: Major | Corporate Officer/Principal | |
River Vision Development Corp.
 River Vision Development Corp. BiotechnologyHealth Technology River Vision Development Corp. develops novel protein therapies. The firm provides therapy for the treatment of graves orbitopathy which is a condition in which an autoimmune response is mounted against tissues behind the eye, causing inflammation, tissue proliferation and excess production of extracellular matrix. The company was founded in 2011 and is headquartered in New York, NY. | Biotechnology | Director/Board Member | |
| DICERNA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
The Column Group LLC
 The Column Group LLC Investment ManagersFinance The Column Group LLC is a venture capital firm founded in 2005 by Peter Svennilson. The firm is headquartered in San Francisco. | Investment Managers | Private Equity Investor | |
Scribe Therapeutics, Inc.
 Scribe Therapeutics, Inc. BiotechnologyHealth Technology Scribe Therapeutics, Inc. engages in the development of in vivo therapies. It develops custom engineered enzymes and delivery modalities as part of a proprietary, evergreen platform for CRISPR-based genetic medicine. The company was founded by Jennifer A. Doudna, Benjamin L. Oakes, David F. Savage, and Brett T. Staahl and is headquartered in Berkeley, CA. | Biotechnology | Founder | |
Tempus Labs, Inc.
 Tempus Labs, Inc. Information Technology ServicesTechnology Services Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL. | Information Technology Services | Director/Board Member | |
TPG Sixth Street Partners LLC
 TPG Sixth Street Partners LLC Investment ManagersFinance TPG Sixth Street Partners LLC (TPG Sixth Street Partners) is a private equity and venture capital firm founded in 2009 by Alan Samuel Waxman and Joshua William Easterly. The firm is headquartered in San Francisco, California. | Investment Managers | Consultant / Advisor | |
Altos Labs, Inc.
 Altos Labs, Inc. BiotechnologyHealth Technology Altos Labs is a biotechnology company that focuses on cellular rejuvenation programming to restore cell health and resilience. The company is based in Redwood City, CA. The company's goal is to reverse disease and transform medicine. Altos Labs was founded by Rick Klausner and Hans Edgar Bishop. The CEO is Hal V. Barron. | Biotechnology | Director/Board Member | |
| Innovative Genomics Institute | Founder | ||
| Li Ka Shing (Canada) Foundation | Corporate Officer/Principal | ||
GSK Equity Investments Ltd.
 GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity Investment Ltd (GSK Equity) is a venture capital firm a subsidiary of GlaxoSmithKline Plc founded in 1985. The firm is headquartered in Reedwood City, California. | Investment Managers | Corporate Officer/Principal | |
| CONSTELLATION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| University of Massachusetts | College/University | Undergraduate Degree | |
| TRANSLATE BIO, INC. | Biotechnology | Director/Board Member | |
| AILERON THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Immune-Onc Therapeutics, Inc.
 Immune-Onc Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Immune-Onc Therapeutics, Inc. operates as a biopharmaceutical company focused on developing innovative therapeutic antibodies for cancer treatment. The company was founded by Charlene Liao and Gui-Liang Yu in 2016 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Director/Board Member | |
Nimbus Therapeutics LLC
 Nimbus Therapeutics LLC BiotechnologyHealth Technology Nimbus Therapeutics LLC provides drug discovery research services. It is a computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinical development. The company was founded by Bruce Lee Booth in 2009 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Lexent Bio, Inc.
 Lexent Bio, Inc. Financial ConglomeratesFinance Lexent Bio, Inc. engages in the development of novel liquid biopsy technologies to manage cancer. The company was founded by Kenneth G. Nesmith, Haluk Tezcan, and John Spinosa and is headquartered in San Francisco, CA. | Financial Conglomerates | Director/Board Member | |
| California State University-East Bay | College/University | Masters Business Admin | |
| TSCAN THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| The King's College (New York) | College/University | Undergraduate Degree | |
| Brody School of Medicine | College/University | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 48 |
| Japan | 2 |
| Canada | 2 |
Sectoraal
| Health Technology | 27 |
| Consumer Services | 12 |
| Finance | 8 |
| Commercial Services | 2 |
| Technology Services | 2 |
Operationeel
| Director/Board Member | 70 |
| Corporate Officer/Principal | 51 |
| Independent Dir/Board Member | 27 |
| Director of Finance/CFO | 19 |
| Undergraduate Degree | 14 |
Sterkste connecties
| Insiders | |
|---|---|
| Christopher Ehrlich | 26 |
| Jennifer Doudna | 26 |
| Michael Hodges | 21 |
| John Smither | 20 |
| Brian Gallagher | 20 |
| Caroline Loewy | 17 |
| Stephen Worland | 12 |
| Barbara Klencke | 12 |
| Michael Byrnes | 10 |
| Elizabeth Bhatt | 9 |
| Mayank J. Gandhi | 8 |
| Kristen Harrington-Smith | 6 |
| Mark Densel | 4 |
- Beurs
- Insiders
- Douglas Warner
- Bedrijfsconnecties
